Your Notifications
All done, no notifications

What is a Ventricular Fibrillation?

Ventricular fibrillation (VF) is a life-threatening heart rhythm in which the ventricles develop rapid, chaotic electrical activity instead of contracting in a coordinated manner. As a result, the heart cannot pump blood effectively to the brain and other vital organs. VF can cause sudden cardiac arrest and requires immediate emergency treatment.

VF is different from ventricular tachycardia, although ventricular tachycardia can sometimes deteriorate into ventricular fibrillation. Without prompt cardiopulmonary resuscitation (CPR) and defibrillation, VF can be fatal within minutes.

What is the Importance of Timely Treatment?

Ventricular fibrillation is a medical emergency, and every minute without effective defibrillation can significantly reduce the chance of survival. Immediate treatment generally involves calling emergency medical services, starting high-quality CPR, using an automated external defibrillator (AED) when available, delivering an electrical shock to restore an organised heart rhythm, and providing advanced cardiac life support while treating the underlying cause. After circulation is restored, patients may require intensive monitoring and additional treatment to reduce the risk of another cardiac arrest.

What are the Common Symptoms of Ventricular Fibrillation?

  • Sudden Collapse: The person may suddenly lose consciousness because the heart can no longer pump blood effectively.
  • Loss of Responsiveness: The individual does not respond to voice or physical stimulation.
  • Absent or Abnormal Breathing: Normal breathing may stop or become irregular, including gasping.
  • No Effective Pulse: A pulse may be absent because there is no effective cardiac output.
  • Sudden Chest Discomfort: Chest pain or pressure may occur before VF, especially when triggered by an acute heart attack.
  • Dizziness or Palpitations: Some patients may experience warning symptoms such as dizziness, rapid heartbeat, or palpitations before collapse, although VF can occur without warning.

Causes and Risk Factors of Ventricular Fibrillation

Causes

  • Acute Myocardial Infarction: A heart attack can disrupt the heart's electrical activity and trigger VF.
  • Coronary Artery Disease: Reduced blood supply to the heart muscle can increase the risk of dangerous ventricular arrhythmias.
  • Cardiomyopathy: Diseases affecting the heart muscle can create electrical instability.
  • Electrolyte Abnormalities: Severe abnormalities in potassium, magnesium, or other electrolytes may trigger ventricular arrhythmias.
  • Inherited Arrhythmia Syndromes: Conditions such as long QT syndrome and Brugada syndrome can increase susceptibility to VF.
  • Severe Heart Failure: Significant impairment of heart function can increase the risk of life-threatening ventricular arrhythmias.
  • Electrical Shock or Major Trauma: Severe electrical exposure or certain forms of trauma can disturb cardiac electrical activity.
  • Certain Medicines or Toxins: Some drugs and toxic substances can prolong or disrupt cardiac electrical activity.

Risk Factors

  • Previous Heart Attack: Previous myocardial injury can leave scar tissue that promotes abnormal electrical activity.
  • Coronary Artery Disease: Significant coronary disease increases the risk of ventricular arrhythmias.
  • Reduced Heart Function: A low left ventricular ejection fraction is associated with increased risk in certain patients.
  • Cardiomyopathy: Structural heart-muscle disorders can increase susceptibility.
  • Family History: A family history of sudden cardiac death or inherited arrhythmia disorders may increase risk.
  • Inherited Electrical Disorders: Long QT syndrome, Brugada syndrome, and other inherited conditions can predispose individuals to VF.
  • Electrolyte Imbalance: Significant potassium or magnesium abnormalities may increase arrhythmia risk.

Latest Research and Technologies in the Treatment of Ventricular Fibrillation in Turkey

  • Recent advances focus on rapid recognition and treatment of cardiac arrest, improved defibrillation technology, high-quality CPR, targeted temperature management in selected post-cardiac-arrest patients, and advanced critical care. Recently, a Turkish Ministry of Health hospital reported implementing a computer-assisted 3D mapping system for arrhythmia ablation in 2026. Modern electrophysiology has also improved risk assessment and prevention of recurrent ventricular arrhythmias. Implantable cardioverter-defibrillators (ICDs) can continuously monitor heart rhythm and deliver therapy when life-threatening ventricular arrhythmias occur.

Treatment options for Ventricular Fibrillation

Defibrillation: An AED or manual defibrillator delivers an electrical shock to stop VF and allow the heart's normal electrical activity to resume.

Coronary Revascularisation: If VF is associated with an acute coronary blockage, urgent coronary angiography and appropriate revascularisation may be required.

Implantable Cardioverter-Defibrillator (ICD) : An ICD continuously monitors heart rhythm and can deliver an electrical shock or pacing therapy if a life-threatening ventricular arrhythmia occurs, in appropriately selected patient.


Cost Start From 20000Explore Options

Catheter Ablation : In selected patients with recurrent ventricular arrhythmias, catheter ablation can target abnormal electrical circuits or scar-related areas responsible for arrhythmia.

Mechanical Circulatory Support: In selected cases of refractory cardiac arrest or severe cardiogenic shock, specialised centres may consider technologies such as extracorporeal membrane oxygenation (ECMO).

  • Clinical assessment:
    • Emergency Assessment: Evaluation of consciousness, breathing, pulse, circulation, and cardiac rhythm during the acute event.
    • Medical History: Assessment of previous heart disease, cardiac arrest, medications, family history, and possible triggers.
    • Electrocardiogram (ECG): Identifies ventricular fibrillation during the acute event and may help detect underlying rhythm or ischaemic abnormalities after stabilisation.
    • Continuous ECG Monitoring: Helps detect recurrent ventricular arrhythmias during hospitalisation.
    • Blood Tests: Electrolytes, cardiac biomarkers, blood glucose, kidney function, and other tests may help identify potential causes.
    • Electrophysiological Study: May be considered in selected patients to evaluate complex electrical abnormalities and guide arrhythmia management.
  • Imaging Tests:
    • Echocardiography: Evaluates heart structure and pumping function and can identify cardiomyopathy or other structural abnormalities.
    • Coronary Angiography: Assesses coronary artery blockages, particularly when VF occurs in suspected acute coronary syndrome.
    • Cardiac MRI: Provides detailed assessment of heart structure, scar tissue, inflammation, and certain cardiomyopathies.
    • CT Angiography: May be used in selected stable patients to evaluate coronary artery anatomy.
    • Chest X-ray: May help assess the heart and lungs and identify associated conditions when clinically indicated.
    • Genetic Testing: May be recommended for selected patients when an inherited arrhythmia or cardiomyopathy is suspected, particularly with a relevant family history.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Ventricular Fibrillation patients in Turkey. These services include:

  • Cardiac Rehabilitation: A structured programme may help appropriate survivors safely regain physical capacity after cardiac arrest, heart attack, or other underlying heart disease.
  • Gradual Physical Activity: Activity increases progressively based on heart function, neurological recovery, and medical recommendations.
  • Physiotherapy: May help address weakness, reduced mobility, or physical deconditioning following prolonged hospitalisation or critical illness.
  • Occupational Therapy: Can support the gradual return to daily activities and functional independence when physical or neurological limitations are present.
  • Medicines are generally used alongside emergency resuscitation and treatment of the underlying cause rather than as a replacement for defibrillation. Depending on the clinical situation, treatment may include antiarrhythmic medicines during or after cardiac arrest, medicines to correct electrolyte abnormalities, antiplatelet or anticoagulant therapy when indicated, and medicines to manage coronary artery disease or heart failure.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Ventricular Fibrillation in Turkey

Medicana International Istanbul: Top Doctors, and Reviews
Medicana International Istanbul

Istanbul, Turkey

Medicana International Istanbul located in Istanbul, Turkey is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

  • Covers an indoor area of 30.000 m
  • Capacity of 191 beds
  • 34 ICUs
  • 8 NICUs
  • 8 Operation Theatres
  • Inpatient Floors
  • Outpatient Floors
  • Internal and Surgical Intensive Unit Care
  • Cardiovascular Surgery Intensive Care Unit
  • Coronary Intensive Care Unit
  • Neonatal Intensive Care Unit
  • Patient comfort CIP, VIP and Standard Patient Rooms
  • Intensive care patient rooms
  • Technology Advancement- PET-CT, ERCP, BT/MR 1.5 Tesla
Message Us
Medicana International Ankara Hospital: Top Doctors, and Reviews
Medicana International Ankara Hospital

Ankara, Turkey

Medicana International Ankara Hospital located in Ankara, Turkey is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

  • Area of 20.000 m2
  • Capacity for 207 bed capacity
  • 8 Operating rooms
  • 26 Observation beds
  • 17 internal and surgical intensive care units
  • 9 cardiovascular intensive care units
  • 10 incubators
  • 5 Coronary Intensive Care Unit
  • Neonatal intensive care unit (NICU)
  • IVF Center
  • Advanced Oncology Unit
  • Bone Marrow Center
  • Organ Transplant Center
  • Cardiology center
  • Obesity Center
  • Clinical Services
  • In-house Pharmacies
  • Parking capacity of 50 vehicles and free valet service
  • Patients rooms are fully equipped and categorized as Suite room, VIP room and standard room
Message Us
Memorial Antalya Hospital: Top Doctors, and Reviews
Memorial Antalya Hospital

Antalya, Turkey

Memorial Antalya Hospital located in Antalya, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • 114 patients and 28 intensive care beds
  • 5 Operating theatres
  • Radiology Department with advanced technology
  • Intensive care units
  • Interventional Radiology Unit
  • Chemotherapy and Art Center
  • The Hospital uses advanced technologies like Hydra Facial, Cardiac MR, Heart Tomography-Coronary CT Angiography and many more
  • Patient rooms and living spaces with all the 5-star hotel features
Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Turkey for Ventricular Fibrillation Treatment?

  • Experienced Cardiac Specialists: Patients can access cardiologists, electrophysiologists, cardiac surgeons, and critical-care specialists experienced in managing life-threatening arrhythmias.
  • Advanced Emergency Cardiac Care: Major cardiac centres may provide emergency departments, coronary care units, cardiac catheterisation laboratories, and advanced resuscitation facilities.
  • Modern Electrophysiology Services: Eligible patients may have access to ICD implantation, catheter ablation, electrophysiological studies, and advanced rhythm monitoring.
  • Advanced Cardiac Imaging: Specialised centres may offer echocardiography, cardiac MRI, CT, coronary angiography, and other diagnostic technologies.
  • Comprehensive Critical Care: Intensive care teams can provide advanced monitoring and organ support after cardiac arrest.
  • Multidisciplinary Treatment: Cardiology, electrophysiology, cardiac surgery, critical care, neurology, rehabilitation, and other specialists can collaborate for complex cases.
  • Personalised Long-Term Care: Treatment and prevention strategies are tailored to the underlying cause, heart function, arrhythmia risk, and overall health.
  • International Patient Support: Many major Turkey hospitals provide international patient services, including appointment coordination, treatment planning, accommodation assistance, and follow-up support.

Frequently Asked Questions

Recovery varies considerably and depends on how quickly circulation was restored, the underlying cause, and whether the brain or other organs were affected. Some patients recover within weeks, while others may require prolonged cardiac, neurological, or physical rehabilitation.

Active ventricular fibrillation is incompatible with effective circulation and requires immediate resuscitation. Survivors may be able to walk and resume physical activity after stabilisation, but they should restart activity under medical guidance based on heart function and the underlying condition.

Many advanced Turkey cardiac centres offer defibrillation, advanced cardiac life support, coronary angiography, electrophysiology services, ICD implantation, catheter ablation, cardiac imaging, intensive care, and cardiac rehabilitation.

Many major Turkey hospitals have international patient departments that help overseas patients with appointments, medical documentation, treatment coordination, accommodation, interpretation (where available), and follow-up arrangements.

Consider the centre's emergency cardiac and intensive-care facilities, electrophysiology expertise, experience with ICD implantation and ventricular arrhythmia management, availability of coronary intervention, advanced imaging, and long-term follow-up services.

There is no single success rate because outcomes depend heavily on how quickly CPR and defibrillation are provided, the underlying cause, the duration of cardiac arrest, neurological status, and the quality of post-arrest care. Early defibrillation and high-quality CPR are important factors associated with better outcomes.

Turkey has cardiologists, electrophysiologists, cardiac surgeons, and critical-care specialists experienced in managing ventricular arrhythmias and cardiac arrest. Patients should choose a centre with appropriate emergency, electrophysiology, and intensive-care expertise.

Risks depend on the treatment and the patient's condition. Defibrillation and CPR may cause complications such as skin burns, chest injury, or rib fractures. ICD implantation and catheter ablation also carry procedure-specific risks, including bleeding, infection, blood-vessel injury, or rhythm complications.

Ventricular fibrillation is a life-threatening heart rhythm disorder, not an injury. If someone suddenly collapses, is unresponsive, or is not breathing normally, call emergency services, begin CPR immediately, and use an AED as soon as one is available.

Ventricular fibrillation does not directly cause physical or skeletal deformities. However, prolonged cardiac arrest can cause brain or other organ injury, which may result in long-term physical, cognitive, or functional disabilities in some survivors.

Yes. Survivors may experience reduced physical capacity, neurological difficulties, emotional distress, anxiety, or fear of recurrence. Appropriate cardiac care, rehabilitation, psychological support, and management of the underlying condition can help improve quality of life.

Ventricular fibrillation is an immediate medical emergency rather than a condition that can safely remain untreated. Without prompt CPR and defibrillation, it can rapidly progress to cardiac arrest, severe brain injury, multiple-organ damage, and death.

Prevention depends on the underlying cause. Managing coronary artery disease, blood pressure, cholesterol, diabetes, and heart failure; avoiding smoking; treating electrolyte abnormalities; taking prescribed medicines correctly; and attending regular cardiology follow-up can reduce risk. Patients at high risk may require an ICD.

Yes. Risk is higher in people with previous heart attacks, coronary artery disease, cardiomyopathy, heart failure, certain inherited arrhythmia syndromes, significant electrolyte abnormalities, or a previous episode of ventricular arrhythmia. Risk also depends on the individual's underlying heart condition.

Author

Tanya Bose
Tanya Bose

MSc Biotechnology

4 Years of Experience

Tanya Bose is a medical content specialist with a strong medical background. She has completed her Bachelor's and Master’s in Biotechnology from Amity University. With a deep understanding of biomedical sciences and research, she develops authoritative and patient-focused medical content covering treatments, surgical procedures, and healthcare innovations. Her writing emphasizes accuracy, clarity, and evidence-based information to help readers better understand complex medical topics. She is dedicated to improving patient awareness and supporting informed healthcare decisions by delivering trustworthy medical insights in a clear and accessible format. View More

Reviewer

Dr. Nityanand Tripathi
Dr. Nityanand Tripathi

Interventional Cardiologist

29 Years of Experience

With a rich experience of more than 29 years, Dr. Nityanand has gained a vast spectrum of skills and expertise in performing all types of complex cardiac procedures. He is an expert in clinical & interventional cardiology and electrophysiology. He studied his medicine (MBBS) and MD from the Institute of Medical Sciences of Banaras Hindu University, Varanasi, and later completed his DM in Cardiology from the prestigious King George Medical University, Lucknow. View More

Last Reviewed - January 2026